- Report
- February 2026
- 250 Pages
Global
From €4179EUR$4,490USD£3,495GBP
- Report
- February 2026
- 250 Pages
Global
From €4179EUR$4,490USD£3,495GBP
- Report
- February 2026
- 250 Pages
Global
From €4179EUR$4,490USD£3,495GBP
- Report
- October 2026
- 267 Pages
Global
From €5445EUR$5,850USD£4,553GBP
- Report
- October 2026
- 566 Pages
Global
From €5445EUR$5,850USD£4,553GBP
- Report
- October 2026
- 365 Pages
Global
From €5445EUR$5,850USD£4,553GBP
- Report
- March 2026
- 150 Pages
Global
From €3490EUR$3,750USD£2,919GBP
- Report
- August 2026
- 150 Pages
Global
From €3490EUR$3,750USD£2,919GBP
- Report
- July 2026
- 400 Pages
Global
From €7436EUR$7,990USD£6,219GBP
- Report
- July 2026
- 200 Pages
Global
From €7436EUR$7,990USD£6,219GBP
- Report
- July 2026
- 295 Pages
Global
From €7436EUR$7,990USD£6,219GBP
- Report
- April 2026
- 30 Pages
Global
From €2559EUR$2,750USD£2,140GBP
- Report
- April 2026
- 30 Pages
Global
From €2559EUR$2,750USD£2,140GBP
- Report
- April 2026
- 225 Pages
Global
From €7436EUR$7,990USD£6,219GBP
- Report
- January 2026
- 450 Pages
Global
From €4653EUR$5,000USD£3,892GBP
- Report
- January 2026
- 180 Pages
Global
From €2792EUR$3,000USD£2,335GBP
- Report
- December 2025
- 200 Pages
Global
From €7399EUR$7,950USD£6,188GBP
- Report
- December 2025
- 200 Pages
Global
From €7399EUR$7,950USD£6,188GBP
- Report
- November 2025
- 200 Pages
Global
From €7399EUR$7,950USD£6,188GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2596EUR$2,789USD£2,171GBP

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases.
In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more